BioNTech SE (BNTX) Free Cash Flow (2018 - 2025)

BioNTech SE has disclosed Free Cash Flow across 8 years of filings, most recently posting $433.8 million for Q4 2025.

• Free Cash Flow for Q4 2025 came in at $433.8 million, up 202.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $815.2 million (up 56.49% YoY), and the FY2025 annual result was $713.0 million, up 35.02% from the prior year.
• Free Cash Flow came in at $433.8 million for Q4 2025 at BioNTech SE, down from $954.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $4.9 billion in Q3 2022 to a low of -$769.8 million in Q1 2025.
• The 5-year median for Free Cash Flow is $687.4 million (2023), against an average of $1.2 billion.
• Across the five-year window, Free Cash Flow jumped 1144001575.84% in 2022 and tumbled 173.79% in 2025, its largest moves.
• BioNTech SE's Free Cash Flow stood at $273.3 million in 2021, then jumped by 260.55% to $985.4 million in 2022, then grew by 2.06% to $1.0 billion in 2023, then plunged by 142.15% to -$423.9 million in 2024, then surged by 202.34% to $433.8 million in 2025.
• The last three Free Cash Flow figures came in at $433.8 million (Q4 2025), $954.7 million (Q3 2025), and $196.5 million (Q2 2025), per Business Quant data.